NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (AMEX: PRW), a bio-pharmaceutical company developing proprietary polysaccharide-based therapeutic compounds in the treatment of cancer and fibrosis, today reported its financial results for the second quarter and six months of fiscal 2008. These results are included in the Company’s Quarterly Report on Form 10-Q for the three and six month period ended June 30, 2008, which has been filed with the SEC.
